Mice with osteoblast-specific overexpression of BMP-4 have been shown to develop severe osteopenia due to increased numbers of osteoclasts, whereas mice overexpressing Noggin, a BMP-4 antagonist, have shown increased bone volume due to reduced numbers of osteoclasts (Kamiya and Mishina, 2011). The gene discussed is BMP4; the disease is Osteopenia.